{"id":510268,"date":"2021-07-07T08:33:19","date_gmt":"2021-07-07T12:33:19","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\/"},"modified":"2021-07-07T08:33:19","modified_gmt":"2021-07-07T12:33:19","slug":"artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\/","title":{"rendered":"Artelo Biosciences to Present at the 2021 Ladenburg Thalmann Healthcare Conference on July 14th"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">LA JOLLA, Calif., July  07, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=n8HIVYMf4e3XX3nzOkXncjZrSAyJs11uYHwtzbk4J45IXbcM6vCLEhyxo9g27gxR3-KW9kNRMDVrgGLdmNQactYxq701ajYbhwPLVyaMub8=\" rel=\"nofollow noopener\" target=\"_blank\">Artelo Biosciences, Inc.<\/a><strong>\u00a0(NASDAQ:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sZErafrpCjNprVSS7VObYekV0XTRbDbUMbYTmnHpRegfFI3-sRF1YN1SfgvsRUjVKSVuZwqVXekRHNz9AVQE17LVPLAfZyuZpFo-1yDHPH8=\" rel=\"nofollow noopener\" target=\"_blank\">ARTL<\/a><\/strong><strong>)<\/strong>, a clinical stage biopharmaceutical company focused on the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, today announced that management will be presenting and hosting 1&#215;1 meetings during the Ladenburg Thalmann Healthcare Conference taking place virtually July 13-14, 2021.<\/p>\n<p align=\"justify\">Gregory D. Gorgas, Artelo\u2019s President and Chief Executive Officer, is scheduled to host a virtual presentation during the event as follows:<\/p>\n<p align=\"justify\">\n        <strong>2021 Ladenburg Thalmann Healthcare Conference<\/strong><br \/>\n        <br \/>Date: Wednesday, July 14, 2021<br \/>Time: 3:00 p.m. EST \/ 12:00 p.m. PST<br \/>Webcast: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LFen6jwiwpN9ZAs4R3DCjnoDVTunXBPdbJIcGjPjT0oHEGiHr2nPH48-sItqrHZK9jcRWbCeAJrwpPBaXsg13UvaDxHHjmU0opaXjaxU7ryLE2a7J3EI5CeBM6tdC7Pt3HI01Ml0L9Pt0WXgHGNkQ0suqfXufxxJti69QqwNqPM=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/wsw.com\/webcast\/ladenburg7\/artl\/2425233<\/a><\/p>\n<p align=\"justify\">\n        <strong>About Artelo Biosciences <\/strong><br \/>\n        <br \/>Artelo Biosciences, Inc.\u00a0is a clinical stage biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics that target lipid signaling pathways, including the endocannabinoid system. Artelo is rapidly advancing a portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including anorexia, cancer, PTSD, pain, and inflammation. Led by proven biopharmaceutical executives collaborating with highly respected researchers and technology experts, the San Diego-based company applies leading edge scientific, regulatory, and commercial discipline to develop high-impact therapies. More information is available at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5Sqn90l7yhjS02XPGBjUK_E5kmQvjZwA9iGDED7HOwXVt53PNBJz3fagf4Fle3QADE8f1VbWx2m94UPyyUjBX0p3hMTuz0xrx-nQoFXIlzNn-_pmThboPACdBBekH7wW0KEl4S6XxG1qjUlRxazBEo3vJcdtR-7Qsfxp0BEaHUHVi7MtCeUSEHNpLJbeovu1VZ15cP58g2BPON93eF7Sz5sv6lCE0Tyb3mha1EysllU=\" rel=\"nofollow noopener\" target=\"_blank\">www.artelobio.com<\/a> and Twitter:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RPxfLBR8aFX2mj4HD7stLmugEr7f4UejXzYHqqW43e6yKXo9CeBEBWC4fJo8GFVFrI3uBj7n2pwEKAonyVAsC0pR-WRSDa3VeaL7WSuM5tY=\" rel=\"nofollow noopener\" target=\"_blank\">@ArteloBio<\/a>.<\/p>\n<p>\n        <strong>Forward Looking Statements<br \/><\/strong><br \/>\n        <br \/>\n        <em>This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and Private Securities Litigation Reform Act, as amended, including those relating to the Company\u2019s product development, clinical and regulatory timelines, market opportunity, competitive position, possible or assumed future results of operations, business strategies, potential growth opportunities and other statement that are predictive in nature. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the industry and markets in which we operate and management\u2019s current beliefs and assumptions. These statements may be identified by the use of forward-looking expressions, including, but not limited to, \u201cexpect,\u201d \u201canticipate,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201cbelieve,\u201d \u201cestimate,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201cshould,\u201d \u201cwould\u201d and similar expressions and the negatives of those terms. These statements relate to future events or our financial performance and involve known and unknown risks, uncertainties, and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include those set forth in the Company\u2019s filings with the Securities and Exchange Commission, including our ability to raise additional capital in the future. Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise, except to the extent required by applicable securities laws.<\/em>\n      <\/p>\n<p>\n        <strong>Investor Relations Contact:<\/strong><br \/>\n        <br \/>Crescendo Communications, LLC<br \/>Tel: 212-671-1020<br \/>Email:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=U5TkLzpUQMFiT-__mCLMXSSP6hLCfb_Txk_NcefuG_VfCiWo-BRg4uemM8oShMiA2FoTrdH-6yLRF85R7yudz4Nhqdg3qEo7S2e96hnJZYc=\" rel=\"nofollow noopener\" target=\"_blank\">ARTL@crescendo-ir.com<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MzQ4NyM0Mjc3Nzg3IzIxODc1NzA=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/f77aed21-c2da-4f9d-a5d1-a07730b4c79c\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LA JOLLA, Calif., July 07, 2021 (GLOBE NEWSWIRE) &#8212; Artelo Biosciences, Inc.\u00a0(NASDAQ:\u00a0ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, today announced that management will be presenting and hosting 1&#215;1 meetings during the Ladenburg Thalmann Healthcare Conference taking place virtually July 13-14, 2021. Gregory D. Gorgas, Artelo\u2019s President and Chief Executive Officer, is scheduled to host a virtual presentation during the event as follows: 2021 Ladenburg Thalmann Healthcare Conference Date: Wednesday, July 14, 2021Time: 3:00 p.m. EST \/ 12:00 p.m. PSTWebcast: https:\/\/wsw.com\/webcast\/ladenburg7\/artl\/2425233 About Artelo Biosciences Artelo Biosciences, Inc.\u00a0is a clinical stage biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics that target lipid signaling pathways, including &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Artelo Biosciences to Present at the 2021 Ladenburg Thalmann Healthcare Conference on July 14th&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-510268","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Artelo Biosciences to Present at the 2021 Ladenburg Thalmann Healthcare Conference on July 14th - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Artelo Biosciences to Present at the 2021 Ladenburg Thalmann Healthcare Conference on July 14th - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LA JOLLA, Calif., July 07, 2021 (GLOBE NEWSWIRE) &#8212; Artelo Biosciences, Inc.\u00a0(NASDAQ:\u00a0ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, today announced that management will be presenting and hosting 1&#215;1 meetings during the Ladenburg Thalmann Healthcare Conference taking place virtually July 13-14, 2021. Gregory D. Gorgas, Artelo\u2019s President and Chief Executive Officer, is scheduled to host a virtual presentation during the event as follows: 2021 Ladenburg Thalmann Healthcare Conference Date: Wednesday, July 14, 2021Time: 3:00 p.m. EST \/ 12:00 p.m. PSTWebcast: https:\/\/wsw.com\/webcast\/ladenburg7\/artl\/2425233 About Artelo Biosciences Artelo Biosciences, Inc.\u00a0is a clinical stage biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics that target lipid signaling pathways, including &hellip; Continue reading &quot;Artelo Biosciences to Present at the 2021 Ladenburg Thalmann Healthcare Conference on July 14th&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-07T12:33:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MzQ4NyM0Mjc3Nzg3IzIxODc1NzA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Artelo Biosciences to Present at the 2021 Ladenburg Thalmann Healthcare Conference on July 14th\",\"datePublished\":\"2021-07-07T12:33:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\\\/\"},\"wordCount\":487,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3MzQ4NyM0Mjc3Nzg3IzIxODc1NzA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\\\/\",\"name\":\"Artelo Biosciences to Present at the 2021 Ladenburg Thalmann Healthcare Conference on July 14th - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3MzQ4NyM0Mjc3Nzg3IzIxODc1NzA=\",\"datePublished\":\"2021-07-07T12:33:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3MzQ4NyM0Mjc3Nzg3IzIxODc1NzA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3MzQ4NyM0Mjc3Nzg3IzIxODc1NzA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Artelo Biosciences to Present at the 2021 Ladenburg Thalmann Healthcare Conference on July 14th\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Artelo Biosciences to Present at the 2021 Ladenburg Thalmann Healthcare Conference on July 14th - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\/","og_locale":"en_US","og_type":"article","og_title":"Artelo Biosciences to Present at the 2021 Ladenburg Thalmann Healthcare Conference on July 14th - Market Newsdesk","og_description":"LA JOLLA, Calif., July 07, 2021 (GLOBE NEWSWIRE) &#8212; Artelo Biosciences, Inc.\u00a0(NASDAQ:\u00a0ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, today announced that management will be presenting and hosting 1&#215;1 meetings during the Ladenburg Thalmann Healthcare Conference taking place virtually July 13-14, 2021. Gregory D. Gorgas, Artelo\u2019s President and Chief Executive Officer, is scheduled to host a virtual presentation during the event as follows: 2021 Ladenburg Thalmann Healthcare Conference Date: Wednesday, July 14, 2021Time: 3:00 p.m. EST \/ 12:00 p.m. PSTWebcast: https:\/\/wsw.com\/webcast\/ladenburg7\/artl\/2425233 About Artelo Biosciences Artelo Biosciences, Inc.\u00a0is a clinical stage biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics that target lipid signaling pathways, including &hellip; Continue reading \"Artelo Biosciences to Present at the 2021 Ladenburg Thalmann Healthcare Conference on July 14th\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-07T12:33:19+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MzQ4NyM0Mjc3Nzg3IzIxODc1NzA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Artelo Biosciences to Present at the 2021 Ladenburg Thalmann Healthcare Conference on July 14th","datePublished":"2021-07-07T12:33:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\/"},"wordCount":487,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MzQ4NyM0Mjc3Nzg3IzIxODc1NzA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\/","name":"Artelo Biosciences to Present at the 2021 Ladenburg Thalmann Healthcare Conference on July 14th - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MzQ4NyM0Mjc3Nzg3IzIxODc1NzA=","datePublished":"2021-07-07T12:33:19+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MzQ4NyM0Mjc3Nzg3IzIxODc1NzA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MzQ4NyM0Mjc3Nzg3IzIxODc1NzA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2021-ladenburg-thalmann-healthcare-conference-on-july-14th\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Artelo Biosciences to Present at the 2021 Ladenburg Thalmann Healthcare Conference on July 14th"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/510268","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=510268"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/510268\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=510268"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=510268"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=510268"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}